Identification
Personal identification
- Full name
- Maria Catarina Mota da Silva
Citation names
- Mota, Catarina
Author identifiers
- Ciência ID
- CC13-C7B0-19F5
Knowledge fields
- Medical and Health Sciences - Clinical Medicine
- Medical and Health Sciences - Basic Medicine - Immunology
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
French | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Intermediate (B1) | |
Spanish; Castilian | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Intermediate (B1) |
Education
Degree | Classification | |
---|---|---|
2016
Concluded
|
Board Certification in Internal Medicine (Especialização pós-licenciatura)
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
|
19.9 |
2015
Concluded
|
Medicine (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
"Towards the use of regulatory T cells for the treatment of human autoimmune diseases" (THESIS/DISSERTATION)
|
Approved with honors and distincion |
2007
Concluded
|
Medicine (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
"-" (THESIS/DISSERTATION)
|
17 values |
Affiliation
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2017/01/01 - Current | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Medicina, Portugal |
Other Careers
Category Host institution |
Employer | |
---|---|---|
2021/11/01 - Current | Assistente (Médica) | CUF, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2015/01/01 - Current | Research Associate at Instituto de Medicina Molecular João Lobo Antunes | Instituto de Medicina Molecular, Portugal |
2019/01/01 - 2021/12/31 | Coordinator of Immune-mediated Diseases Group of Medicine Department (CHLN) | Centro Hospitalar Universitário Lisboa Norte EPE, Portugal |
2017/01/01 - 2021/10/31 | Attending Physician in Internal Medicine at Hospital Universitário de Santa Maria/ Centro Hospitalar Lisboa Norte, EPE | Centro Hospitalar Universitário Lisboa Norte EPE, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2022/01/01 - Current | Regulation of protective-antibody versus autoantibody production in human autoimmunity
EXPL/MEC-MGI/1644/2021
Principal investigator
|
Ongoing
|
2009/01/01 - 2015/01/01 | Towards the therapeutic use of regulatory T cells for the treatment of human autoimmune diseases
SFRH/ SINTD/ 60059/ 2009
PhD Student Fellow
|
Concluded
|
2009/01/01 - 2013/01/01 | Factores celulares e moleculares no desenvolvimento de células T reguladoras humanas
PTDC/SAU-IMU/113541/2009
Technical development
|
Concluded
|
Outputs
Publications
Journal article |
|
Distinctions
Award
2021 | Research Grant from the Portuguese Society of Internal Medicina. Understanding the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Severity of COVID-19 Lung Infection. |
2021 | NEDAI 2021 Basic Research Award in Autoimmunity. Regulation of Protective-antibody and Autoantibody Production in Human Autoimmunity |
2015 | NEDAI 2015 Research Award in Autoimmunity |
2012 | Immunity Best Poster Prize |
2012 | Excellence Award in Immunology Mário Arala-Chaves |
2010 | Internal Medicine Portuguese Society Best Poster Prize |